Giulia Scartabellati

The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study

M. Brunelli, S. Buti, M. Santoni, 2023, Therapeutic advances in urology.

The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma

S. Buti, M. Bersanelli, A. Cortellini, 2022, Anti-cancer drugs.

Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?

M. Brunelli, S. Buti, U. de Giorgi, 2023, Expert review of anticancer therapy.